This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
zacks-consensus-estimate: Archive
Wall Street Analysts Believe Deluxe (DLX) Could Rally 37.04%: Here's is How to Trade
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 37% in Deluxe (DLX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
DLXNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
INPLAY OIL CP (IPOOF) Q2 Earnings Miss Estimates
by Zacks Equity Research
INPLAY OIL CP (IPOOF) delivered earnings and revenue surprises of -80.77% and +3.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
IPOOFPositive Net Change CSIQPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Earnings Growth & Price Strength Make HCA Healthcare (HCA) a Stock to Watch
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
HCAPositive Net Change
earnings-estimates growth-investing zacks-consensus-estimate zacks-rank
New to Investing? This 1 Retail and Wholesale Stock Could Be the Perfect Starting Point
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
WMTNegative Net Change
earnings-estimates growth-investing zacks-consensus-estimate zacks-rank
VYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
VYNE Therapeutics (VYNE) delivered earnings and revenue surprises of +43.48% and -31.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
VYNEPositive Net Change CASIPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Clene Inc. (CLNN) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Clene (CLNN) delivered earnings and revenue surprises of -59.18% and -73.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CLNNNegative Net Change RNANegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Oncobiologics, Inc. (OTLK) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Oncobiologics (OTLK) delivered earnings and revenue surprises of -4.76% and -40.98%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
OTLKPositive Net Change CVACPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Lifeward (LFWD) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Lifeward (LFWD) delivered earnings and revenue surprises of -132.00% and -11.53%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
LFWDNegative Net Change WDAYNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
MeiraGTx Holdings PLC (MGTX) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
MeiraGTx (MGTX) delivered earnings and revenue surprises of +7.69% and +59.78%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
MGTXNegative Net Change CLNNNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
CoreCard Corporation (CCRD) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
CoreCard (CCRD) delivered earnings and revenue surprises of +14.81% and +6.95%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CCRDNegative Net Change NEXCFNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
PagSeguro Digital Ltd. (PAGS) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
PagSeguro Digital (PAGS) delivered earnings and revenue surprises of +9.68% and -0.66%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PAGSNegative Net Change CRGONegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
AFC Gamma Inc. (AFCG) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
AFC Gamma (AFCG) delivered earnings and revenue surprises of -37.50% and -18.17%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AFCGNegative Net Change EARNNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
LM Funding America, Inc. (LMFA) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
LM Funding America (LMFA) delivered earnings and revenue surprises of +103.85% and +7.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
LMFAPositive Net Change FPAYPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Spartan Stores (SPTN) Q2 Earnings Top Estimates
by Zacks Equity Research
Spartan Stores (SPTN) delivered earnings and revenue surprises of +20.00% and -1.38%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
SPTNNegative Net Change WSMNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Xilio Therapeutics, Inc. (XLO) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Xilio Therapeutics (XLO) delivered earnings and revenue surprises of -100.00% and -10.38%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
XLONegative Net Change MGTXNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Canaan (CAN) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Canaan (CAN) delivered earnings and revenue surprises of +76.92% and +1.89%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CANNegative Net Change HIVEPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Cellebrite DI Ltd. (CLBT) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Cellebrite DI Ltd. (CLBT) delivered earnings and revenue surprises of +20.00% and +0.75%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CLBTPositive Net Change PATHNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
MediWound (MDWD) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
MediWound (MDWD) delivered earnings and revenue surprises of -123.64% and +1.89%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
MDWDNegative Net Change NTRBNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Air Industries (AIRI) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Air Industries (AIRI) delivered earnings and revenue surprises of +26.67% and +5.49%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AIRINegative Net Change AVAVNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Tapestry (TPR) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Tapestry (TPR) delivered earnings and revenue surprises of +2.97% and +2.30%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
TPRNegative Net Change FLNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Dillard's (DDS) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Dillard's (DDS) delivered earnings and revenue surprises of +22.96% and +0.20%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?
DDSPositive Net Change MNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Advance Auto Parts (AAP) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Advance Auto Parts (AAP) delivered earnings and revenue surprises of +16.95% and +0.90%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AAPNegative Net Change ROSTNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
QXO, Inc. (QXO) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
QXO INC (QXO) delivered earnings and revenue surprises of +175.00% and +1.86%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
QXONegative Net Change BTDRNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Applied Industrial Technologies (AIT) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Applied Industrial Technologies (AIT) delivered earnings and revenue surprises of +7.69% and +3.74%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AITNegative Net Change NDSNNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Adherex Technologies Inc. (FENC) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Adherex Technologies (FENC) delivered earnings and revenue surprises of -83.33% and +1.76%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
FENCNegative Net Change OCSNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank